97. Anne Neuenschwander, Chiara Lonati, Luca Antonelli, et al. Treatment Outcomes for Men with Clinical Stage II Nonseminomatous Germ Cell Tumours Treated with Primary Retroperitoneal Lymph Node Dissection: A Systematic Review. Eur Urol Focus . 2023 May;9(3):541-546. doi: 10.1016/j.euf.2022.11.003.
98. Gordon J Rustin, Graham M Mead, Sally P Stenning, et al. Randomized trial of two or five computed tomography scans in the surveillance of patients with stage I nonseminomatous germ cell tumors of the testis: Medical Research Council Trial TE08, ISRCTN56475197--the National Cancer Research Institute Testis Cancer Clinical Studies Group. J Clin Oncol . 2007 Apr 10;25(11):1310-5. doi: 10.1200/JCO.2006.08.4889.
99. Johnathan K Joffe, Fay H Cafferty, Laura Murphy, et al. Imaging Modality and Frequency in Surveillance of Stage I Seminoma Testicular Cancer: Results From a Randomized, Phase III, Noninferiority Trial (TRISST). J Clin Oncol. 2022 Aug 1;40(22):2468-2478. doi: 10.1200/JCO.21.01199.
100. Andrea Necchi, Nicola Nicolai, Luigi Mariani, et al. Combination of paclitaxel, cisplatin, and gemcitabine (TPG) for multiple relapses or platinum-resistant germ cell tumors: long-term outcomes. Clin Genitourin Cancer. 2014 Feb;12(1):63-69.e1. doi: 10.1016/j.clgc.2013.07.005.
101. R T D Oliver, M D Mason, G M Mead, H von der Maase, G J S Rustin, J K Joffe, et al. Radiotherapy versus single-dose carboplatin in adjuvant treatment of stage I seminoma: a randomised trial. Lancet. 2005 Jul;366(9482):293-300. doi: 10.1016/S0140-6736(05)66984-X.
102. Meghan Mastrangelo. Cisplatin-Based Therapy and CINV: Optimal Antiemetics During Germ Cell Testicular Cancer Treatment. CJON 2018, 22(2), E31-E36. DOI: 10.1188/18.CJON.E31-E36
103. Vanessa Piechotta, Anne Adams, Madhuri Haque, Benjamin Scheckel, Nina Kreuzberger, Ina Monsef, Karin Jordan, Kathrin Kuhr, Nicole Skoetz. Antiemetics for adults for prevention of nausea and vomiting caused by moderately or highly emetogenic chemotherapy: a network meta-analysis. Cochrane Database Syst Rev, 2021 Nov 16;11(11):CD012775
104. Владимирова Л.Ю., Гладков О.А., Королева И.А., Румянцев А.А., Семиглазова Т.Ю., Трякин А.А., Кутукова С.И., Овчинникова Е.Г., Новикова О.Ю., Корниецкая А.Л. Практические рекомендации по профилактике и лечению тошноты и рвоты у онкологических больных. Практические рекомендации RUSSCO, часть 2. https://rosoncoweb.ru/standarts/?chapter=nausea_vomiting
105. Chaoyang Chen, Ruoming Li, Ting Yang. Denosumab Versus Zoledronic Acid in the Prevention of Skeletal-related Events in Vulnerable Cancer Patients: A Meta-analysis of Randomized, Controlled Trials. Clinical Therapeutics 2020, 42(8): 1494–1507.e1.
106. Багрова С.Г., Басин Е.М., Борзов К.А., Бычкова Н.М., Деньгина Н. В., Копп М.В., Крылов В.В., Кочетова Т.Ю., Семиглазова Т.Ю. Профилактика и лечение патологии костной ткани при злокачественных новообразованиях. Практические рекомендации RUSSCO, часть 2.
https://rosoncoweb.ru/standarts/?chapter=bone_pathology
107. Fankhauser CD, Tran B, Pedregal M, Ruiz-Morales JM, Gonzalez-Billalabeitia E,et al.. A Risk-benefit Analysis of Prophylactic Anticoagulation for Patients with Metastatic Germ Cell Tumours Undergoing First-line Chemotherapy Eur Urol Focus. 2021 Sep;7(5):1130-1136. doi: 10.1016/j.euf.2020.09.017.
108. Chinthaka B Samaranayake, James Anderson, Colm McCabe, Syeda Farah Zahir, John W Upham, Gregory Keir, Direct oral anticoagulants for cancer-associated venous thromboembolisms: a systematic review and network meta-analysis, Intern Med J,2022 Feb;52(2):272-281.
109. William Knoll, Nathan Fergusson, Victoria Ivankovic , Tzu-Fei Wang, Lucia Caiano, Rebecca Auer, Marc Carrier, Extended thromboprophylaxis following major abdominal/pelvic cancer-related surgery: A systematic review and meta-analysis of the literature, Thromb Res, 2021 Aug:204:114-122.
110. Сомонова О.В., Антух Э.А., Варданян А.В., Громова Е.Г., Долгушин Б.И., Елизарова А.Л., Сакаева Д.Д., Сельчук В.Ю., Трякин А.А., Черкасов В.А. Практические рекомендации по профилактике и лечению тромбоэмболических осложнений у онкологических больных. Практические рекомендации RUSSCO, часть 2. https://rosoncoweb.ru/standarts/?chapter=thromboembolism
111. NCCN Guidelines. Prevention and Treatment of Cancer-Related Infections. v.1, 2021. https://www.nccn.org/professionals/physician_gls/pdf/infections.pdf.
112. Yoshimasa Kosaka, Yoshiaki Rai, Norikazu Masuda, et al. Phase III placebo-controlled, double-blind, randomized trial of pegfilgrastim to reduce the risk of febrile neutropenia in breast cancer patients receiving docetaxel/cyclophosphamide chemotherapy. Support Care Cancer 2015 Apr;23(4):1137–43.
113. Mical Paul, Dafna Yahav, Abigail Fraser, Leonard Leibovici. Empirical antibiotic monotherapy for febrile neutropenia: systematic review and meta-analysis of randomized controlled trials. Journal of Antimicrobial Chemotherapy, Volume 57, Issue 2, February 2006, Pages 176–189.
114. Сакаева Д.Д., Борисов К.Е., Булавина И.С., Когония Л.М., Курмуков И.А., Орлова Р.В., Шабаева М.М. Практические рекомендации по диагностике и лечению фебрильной нейтропении. Практические рекомендации RUSSCO, часть 2. https://rosoncoweb.ru/standarts/?chapter=febrile_neutropenia
115. B Vincenzi, A Russo, A Terenzio, et al. The use of SAMe in chemotherapy-induced liver injury. Crit Rev Oncol Hematol 2018 Oct;130:70–77.
116. Devika Remash, David S Prince, Catriona McKenzie, et al. Immune checkpoint inhibitor-related hepatotoxicity: A review. World J Gastroenterol 2021 Aug 28;27(32):5376–5391.
117. Ткаченко П.Е., Ивашкин В.Т., Маевская М.В. Практические рекомендации по коррекции гепатотоксичности, индуцированной противоопухолевой терапией. Практические рекомендации RUSSCO, часть 2. https://rosoncoweb.ru/standarts/?chapter=hepatotoxicity
118. Zhujun Mao, Keping Shen, Limin Zhu, et al. Comparisons of Cardiotoxicity and Efficacy of Anthracycline-Based Therapies in Breast Cancer: A Network Meta-Analysis of Randomized Clinical Trials. Oncol Res Treat 2019;42(7-8):405–413.